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doi:10.1016/j.ejvs.2008.11.032Abstract Acute aortic dissection is a rare but deadly disease first described over 200 years
ago by the physician to the late King George II on necropsy. Over the ensuing 2 centuries,
the understanding of the pathophysiology, presentation, diagnosis, treatment and follow-up
has matured. In an effort to understand the contemporary treatment of this disease, the Inter-
national Registry of Acute Aortic Dissection (IRAD) has enrolled over 2000 patients over the
past 12 years. In this article we summarize the key lessons learned from this multi-national
registry of patients presenting with acute aortic dissection.
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Acute aortic dissection was first described by Dr. Nich-
olls, physician to the late king George II on necropsy over
200 years ago. Since that time, acute aortic dissection
(AAD) continues to be one of the most feared pain
syndromes because of its high morbidity and mortality.
Hirst and Kime published their seminal article in 1958
describing a 1e2% per hour mortality rate early after, MSc, Assistant Professor, Univer
(111B), 1055 Clermont St., Denve
nver.edu (T.T. Tsai).
td on behalf of European Societysymptom onset from an ascending aortic dissection.1 The
speed of lethality and the mode of death which often
involves severe physiologic derangements from compli-
cations such as pericardial tamponade, myocardial
infarction, malperfusion syndromes to the brain, kidney,
spinal cord and/or gut or frank exsanguination from
aortic rupture has magnified the importance of early
diagnosis and treatment which continues to be critical to
survival.sity of Colorado Denver, Director, Interventional Cardiology, Denver
r, CO 80220, USA. Tel.: þ1 303 399 8020x6105/2385 (office); fax: þ1
for Vascular Surgery.
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its relative rarity and its ability to mimic other more
common conditions. For instance, the prevalence of coro-
nary artery disease is 100e200 times more common then
aortic dissection and it’s incidence in the emergency room
has been estimated to be 3 aortic dissections for every 1000
patients presenting with chest and/or back pain.2e4 Addi-
tionally, estimating the true incidence of aortic dissection
is a difficult undertaking. This stems from the number of
aortic catastrophes that go undiagnosed and result in
sudden death. Because many of these cases are in the
elderly, autopsies are often deferred. Among patients on
whom autopsy was performed, large series have shown the
prevalence of aortic dissection ranges from 0.2% to 0.8%.5,6
With the highmorbidity andmortality of AAD coupledwith
its relative low incidence, research in aortic dissection has
largely been concentrated on single center registries enrolled
over decades to allow for adequate numbers of patients for
comparison and long-term follow-up. However, the treat-
ment for aortic dissection is a rapidly moving field with
evolving surgical techniques, anesthesia, cardiopulmonary
support, ICU and follow-up care. The urgency to collect data
on larger numbers of patients over a shorter period of time
was necessary to effectively describe the clinical course,
management, and outcomes of this aggressive disease.
History of IRAD
Hoping to overcome the small numbers of patients enrolled
at single centers over decades, three investigators
convened at the American College of Cardiology symposium
in 1995 to discuss combining their individual efforts to
create a multi-center registry of aortic dissection. In 1996,
the International Registry of Acute Aortic Dissection (IRAD)
was established with the mission to better understand the
presentation, diagnosis, management, and outcomes of
patients presenting with acute aortic dissection in the
modern era. By 2000, over 450 patients had been enrolled
from 12 international aortic referral centers and its first
paper was published.7 Over the ensuing 8 years, IRAD has
grown to include over 2000 patients from 26 sites and has
now published over 33 papers to date.Table 1 Demographics and history of patients with acute aorti
Variable na(%) Type A, n(%) (
Demographics
Age, mean (SD), y 63.1 (14.0) 61.2 (14
Male 303 (65.3) 182 (63.
Patient history
Marfan syndrome 22/449 (4.9) 19 (6.7
Hypertension 326/452 (72.1) 194 (69.
Atherosclerosis 140/452 (31.0) 69 (24.4
Prior aortic dissection 29/453 (6.4) 11 (3.9
Prior aortic aneurysm 73/453 (16.1) 35 (12.4
Diabetes 23/451 (5.1) 12 (4.3
Prior cardiac surgery 83 (17.9) 46 (15.9
NZ 464.
Reproduced with permission from JAMA.7
a Denominator of reported responses is given if different than stateIn the present report, we will review what IRAD has
learned from these 2000 patients regarding the clinical
presentation, prognosis, diagnostic imaging, therapeutic
approaches and follow-up in the management of AAD.
Design
25 large referral centers in 12 countries are participating in
this registry. All patients with AAD were enrolled beginning
January 1st, 1996. Patients are identified at presentation or
by searching hospital discharge diagnosis records and
surgical and echocardiography laboratory databases. Diag-
nosis was based on history, imaging study findings, visuali-
zation at surgery, and/or post-mortem examination.
Patients with aortic dissection secondary to trauma were
excluded. A dataform of 290 variables, defined according to
standard definitions, including demographics, history,
physical findings, management, imaging studies, and
outcomes was developed by IRAD investigators. Data were
collected at presentation or by physician review of hospital
records. Forms were then forwarded to the IRAD coordi-
nating center at the University of Michigan and reviewed for
internal consistency and face validity and then scanned into
an Access database. External validation was performed
during the inception phase through a random (5%) field
selection and error audit. During this phase, 33% of patient
report forms were re-reviewed for validation by each site.
Yearly follow-up data were obtained for 5 years after
discharge with standardized forms. Collected data included
variables on clinical, imaging, and mortality data. When
applicable, missing data on mortality were obtained
through the Social Security Death Index. At each enrolling
hospital, study investigators worked with their ethics or
institutional review board to obtain appropriate approval to
participate. Full details of the IRAD structure and methods
have been previously published.7
Epidemiology
With our first publication in 2000, we reported on the first
450 patients enrolled in the registry. Two-thirds of thec dissection
NZ 289) Type B, n(%) (NZ 175) P, type A versus B
.1) 66.3 (13.2) <0.001
0) 121 (69.1) 0.18
) 3 (1.8) 0.02
3) 132 (76.7) 0.08
) 71 (42) <0.001
) 18 (10.6) 0.005
) 4 (2.3) 0.006
) 11 (6.6) 0.29
) 37 (21.2) 0.16
d in column heading.
Table 2 Prior cocaine use in IRAD
Variable No history
of cocaine
(nZ 916)
Cocaine before
dissection
(nZ 5)
P
Type A 575 (62.8) 1 (20) 0.068
Type B 341 (37.2) 4 (80)
Age, years 62.4 13.8 44.4 3.9 <0.001
Black race 17 (2.0) 4 (80) <0.001
Prior hypertension 658 (72.3) 5 (100) 0.330
Marfan’s syndrome 48 (4.3) 0 (0) 
Presentation
hypertensive
408 (46.2) 4 (80) 0.189
Myocardial ischemia 76 (8.8) 1 (25) 0.311
Myocardial infarction 43 (5.0) 0 (0) 
Mortality 211 (23) 2 (40) 0.328
Values are number of patients (%) or mean SD. Reproduced
with permission from Circulation.9
Figure 1 14-day mortality in 645 patients from IRAD strati-
fied by medical and surgical treatment in both type A and B
aortic dissection. Reproduced with permission from JAMA.7
Figure 2 Unadjusted KaplaneMeier survival curve stratified
by in-hospital management from date of hospital discharge in
patients with Acute type A aortic dissection. Reproduced with
permission from Circulation.18
Acute Aortic Dissection 151patients were male with a mean age of 63.1 years old (95%
confidence interval, 61.8e64.4 years).7 Type A dissection
was more common accounting for 61.2% of the cases
(Table 1). A history of cardiac surgery was present in 17.9%
of patients, 31.0% have known atherosclerosis and the most
common risk condition for aortic dissection was systemic
hypertension (72.1%). Other risk conditions such as Marfan
syndrome and iatrogenic dissections were infrequent,
occurring in 4.9% and 4.3% respectively.
Other risk factors such as cocaine use have also been
explored in IRAD. Hsue and colleagues reported that 14/38
(37%) of patients admitted to their inner-city hospital over
20 years reported using cocaine in the minutes or hours
proceeding their presentation.8 IRAD had enrolled 921 cases
of AAD at that time of which only 5 (0.5%) were associated
with cocaine use.9 This discrepancy in numbers likely
represents the heterogeneity of patient groups in different
cities as well as the different likelihood of being asked
questions regarding illicit drug use and the documentation
in the medical record. However, aspects of the IRAD
experience did confirm some of the observations of Hsue et
al. When complications of cocaine use do strike the aorta,
it usually does so in the descending aorta and generally
afflicts predominantly young, black, hypertensive individ-
uals. It has been postulated that cocaine users have
premature atherosclerosis from abnormal lipoprotein
homeostasis which can lead to weakening of the aortic wall
leaving it to be more amenable to injury due to the
profound sympathetic stimulation of cocaine abuse.10e12
(Table 2). Nonetheless, these rare but preventable expo-
sures must not be forgotten as potential causes of an acute
aortic dissection and must be asked about in the routine
review of systems of patients presenting with chest and/or
back pain syndromes.
Natural History and Prognosis
Type A (proximal) dissection
AAD of the ascending aorta is highly lethal in the absence of
surgical treatment. However, even in the presence of earlyidentification and timely surgery, operative mortality
remains high. Different reports from single centers and/or
single surgeons have reported mortality rates between 7%
and 30%.13e15 Some of these studies are from single center
cohorts stretching over decades or studies focusing on the
surgically treated cohort only and not all patients pre-
senting to their institution. This excludes the high risk
patients who are either turned down for surgery or die in
the operating room. Others do not distinguish between
Type A or B dissections or their acuity thereby mixing high
and low risk groups. IRAD was designed to enroll consecu-
tive patients from a broad geographic region to minimize
inherent biases seen in small surgical registries.
The in-hospital mortality rate for acute type A patients
in IRAD receiving surgery was 26.6% and 55.9% for those
treated with medical therapy alone (overall 32.5%) (Fig. 1).
Therefore, nearly 1 in 3 patients will die after presenting to
centers with extensive expertise and interest in aortic
dissection in the real world. Furthermore, this is likely an
under-estimation of mortality given that over 60% of IRAD
patients are transferred from outside facilities. Patients
who die at the transferring facility or on route are not
captured in IRAD. Patients who reach an IRAD facility alive
have already undergone an element of selection. Predictors
152 T.T. Tsai et al.of in-hospital death were age > 70 years old (OR, 1.70: 95%
CI, 1.05e2.77; PZ 0.03); abrupt onset of chest pain (OR,
2.60: 95% CI, 1.22e5.54; PZ 0.01); hypotension/shock/
tamponade (OR, 2.97: 95% CI, 1.25e3.29; PZ 0.004); and
abnormal ECG (OR, 1.77: 95% CI, 1.06e2.95; PZ 0.03).16
Similar to coronary artery disease, gender is predictive of
adverse events in acute aortic syndromes. In-hospital
complications of hypotension and tamponade occurred with
greater frequency in women and surgical outcomes were
worse in women compared to men ultimately resulting in
higher in-hospital mortality (PZ 0.013).17
The short- and long-term follow-up survival of acute
type A patients has also been variable with reported
survival rates between 52% and 94% at one year and 45 and
88% at 5 years.18 Our registry provides a unique opportunity
to evaluate long-term mortality rates over a short span of
enrollment (1996e2003) minimizing the impact of changing
strategies of care such as surgical techniques, anesthesia,
cardiopulmonary support, ICU care and follow-up imaging
for surveillance after discharge. IRAD examined 303
patients who survived to hospital discharge and had docu-
mented clinical follow-up data. 273 (90.1%) patients were
managed surgically and 30 (9.9%) were managed medically.
Survival for patients treated with surgery was 96.1% 2.4%
and 90.5%þ 3.9% at 1 and 3 years versus 88.6%þ 12.2% and
68.7%þ 19.8% without surgery (mean follow-up overall 2.8
years, log rank PZ 0.009) Fig. 2. Therefore, in contrast to
the high-mortality rates seen during the initial hospitali-
zation and peri-operative period, contemporary 1- and
3-year survival in patients who are repaired and survive to
hospital discharge is excellent.
Type B (distal) dissection
In-hospital outcomes are generally acceptable in patients
with uncomplicated acute type B dissection, 90% of whom
survive to hospital discharge after receiving effective
antihypertensive therapy.19 In patient presenting withTable 3 In-hospital management and outcomes of all patients
Variable Ove
Definitive management
Surgery (%) 56
Medical Rx (%) 282
Percutaneous intervention (stent, fenestration) (%) 46
Initial medical treatment (excluding hypotensive patients)
Beta-blockers (%) 277
All in-hospital complications (including post-operative)
Coma/altered consciousness (%) 19
Branch vessel involvement (%) 76
Hypotension/shock (%) 40
Malperfusion (%)a 72
Acute renal failure (%) 46
Mesenteric ischemia/infarction (%) 18
Limb ischemia (%) 24
*Chi-square P-value for differences in survival by management.
aMalperfusion is defined for a patient having one of the three conditi
Reproduced with permission from Circulation.19evolving complications such as signs of imminent rupture,
expansion, retrograde dissection, or malperfusion
syndromes, classic open surgery for acute type B aortic
dissection carries a 14%e67% risk of irreversible spinal
injury or post-operative mortality.20e22
In IRAD, overall in-hospital mortality was 13% with most
deaths occurring within the first week. In patients with
indications for surgery, mortality was 32.1% versus 9.6%
when treated with medical therapy alone and 6.5% when
treated by an endovascular approach (Table 3). After
adjusting for age and gender, 3 key variables collectively
named ‘‘the deadly triad’’ emerged as highly significant
predictors of death: hypotension/shock (odds ratio [OR]
23.8, P< 0.001), absence of chest/back pain on presenta-
tion [OR 3.5, PZ 0.01], and branch vessel involvement [OR
2.9, PZ 0.02].19 In patients who survived to hospital
discharge, three-year survival for patients treated medi-
cally, surgically, or with endovascular therapy was
77.6 6.6%, 82.8 18.9%, and 76.2 25.2%, respectively
(median follow-up 2.3 years, log-rank PZ 0.61) (Fig. 3).
Independent predictors of follow-up mortality included
female gender (HR, 2.17; 95% CI, 1.03e4.59; PZ 0.04),
a history of atherosclerosis (HR, 2.48; 95% CI, 1.32e4.66;
p< 0.01), in-hospital renal failure (HR, 2.55; 95% CI, 1.15e
5.63; PZ 0.02), pleural effusion on chest radiograph (HR,
2.56; 95% CI, 1.18e5.58; PZ 0.02), and in-hospital hypo-
tension/shock (HR, 12.5; 95% CI, 3.24e48.21; P< 0.01).23
Intramural hematoma (IMH)
The natural history of acute intramural hematoma
continues to be debated. In patients presenting with acute
aortic syndromes, acute IMH accounts for 5e20% of
cases.24,25 Regression is seen in approximately 10% of
patients but progression to classic aortic dissection occurs in
28e47% of patients and carries a risk of rupture in 20e45%.26
However, Asian registries have suggested that IMH is a more
benign condition in which aggressive medical therapy andwith type B aortic dissection
rall Survived Died P-value
(15) 38 (67.9) 18 (32.1) <0.0001*
(73) 255 (90.4) 27 (9.6)
(12) 43 (93.5) 3 (6.5)
(78.7) 253 (79.6) 24 (70.6) 0.22
(5.1) 8 (2.5) 11 (23.9) <0.0001
(21.6) 56 (18.1) 20 (46.5) <0.0001
(11.7) 15 (5.0) 25 (61.6) <0.0001
(20.6) 52 (17.0) 20 (45.5) <0.0001
(13.5) 36 (11.8) 10 (26.3) 0.01
(5.3) 12 (4.0) 6 (15.8) 0.002
(7.1) 17 (5.7) 7 (17.5) 0.006
ons listed below.
Figure 3 Unadjusted KaplaneMeier survival curve stratified
by in-hospital management of patients with acute type B
dissection who survive to hospital discharge. Reproduced with
permission from Circulation.23
Figure 4 In-hospital mortality for IMH according to site of
origin. IMH was defined after first imaging test failed to
demonstrate IMH or dissection but second test confirmed IMH
or first study showed IMH but no evidence of dissection.
Reproduced with permission from Circulation.30
Acute Aortic Dissection 153serial imaging may allow for watchful waiting and the
avoidance of surgery in selected patients.27e29 These
protocols often include serial imaging studies at frequent
intervals which may not be practical in the current practice
environment in the West. In the IRAD registry of 1010
patients with AAD, 58 (5.7%) patients had IMH.30 This cohort
tended to be older (68.7 versus 61.7 years; p< 0.001) and
more likely to have distal aortic involvement (60.3% versus
35.3%; p< 0.0001). The investigators demonstrated an
association between increasing hospital mortality and the
proximity of IMH to the aortic valve, irrespective of medical
or surgical treatment (9 of 12 deaths occurred in the
ascending aorta) (Fig. 4).
Clinical Manifestations
The art of the diagnosis of AAD has evolved since the advent
of rapid advanced imaging techniques and therapeutic
modalities. The clinical manifestations are diverse and
overlap with a broad differential diagnosis requiring a high
index of suspicion to pursue and aggressively treat this
disorder. Coupled with it’s relative infrequency compared
to other pain syndromes presenting to the emergency room,
the diagnosis of AAD has been missed on initial exam in up
to 38% of patients, and the diagnosis first established at
post-mortem examination in up to 28% of patients.7,31
Patients often complain of the sudden onset of excru-
ciating chest and/or back pain, radiating to the neck or
shoulders. This is distinct from pain of coronary ischemia
which can be more gradual and often less abrupt. In IRAD,
the most common presenting symptom are the abrupt onset
of pain, frequently described as severe or the ‘‘worst ever’’
in 84.8% of patients. The majority described the quality of
the pain as sharp (64.4%) more often then tearing or ripping
and localized the pain to the chest (72.7%).7 Patients with
acute type B dissection more often experienced pain in the
back or abdomen, although there was substantial overlap.
Syncope is a well-recognized symptom of AAD, often
indicating the development of dangerous complications
such as cardiac tamponade, obstruction of cerebral vessels
or activation of cerebral baroreceptors. Syncope wasFigure 5 KaplaneMeier survival curves from patients with
and without pulse deficits; log-rank for curves of patients with
1, 2, or 3 or more pulse deficits differ from patients with no
pulse deficits (P_0.03 and 0.004). Reproduced with permission
from Am J Cardiol.35
154 T.T. Tsai et al.reported in 13% of patients in the IRAD registry.32 These
patients were more likely to die in the hospital (34% versus
23% without syncope) and were more likely to have had
a proximal dissection (ORZ 5.5; P< 0.001), cardiac tam-
ponade (ORZ 3.1; P< 0.001), or a stroke (ORZ 3.5;
P< 0.001). Therefore physicians must be vigilant regarding
patients who present with syncope in the setting of chest
pain and consider AAD and its major sequelae. Pulse deficits
occurred in 30% of the patients in IRAD and are similar to
the 30e50% of patients reported previously in other
studies.33,34 Like other reports, there is an incremental
additive risk of in-hospital death with the number of pulse
deficits noted on physical exam. This often serves as
a surrogate finding indicating the extent of vascular
compromise (Fig. 5).35
Perhaps the most challenging diagnostic cases of AAD are
in those who present with abdominal pain or a painless
aortic dissection. In IRAD, we reported on 46 patients (4.6%)
who presented primarily with abdominal pain. Specifically
in patients with acute type B dissection, in-hospital
mortality was significantly higher (28% versus 10.2%;
pZ 0.02) and was associated with a higher incidence of
malperfusion syndromes. We also reported on 63 (6.4%)
patients who presented with a painless aortic dissection.36
These patients more commonly presented with a history of
diabetes (10.2%), previous aortic aneurysm (29.5%), and
prior cardiovascular surgery (48.1%) and often presented
with syncope (33.9%), congestive heart failure (19.7%) and
stroke (11.3%). Because of these atypical features above
and confounding comorbidites, in-hospital mortality was
higher in the patients who presented with a painless
dissection versus a painful dissection (33.3% versus 23.2%,
pZ 0.05).
After presentation to the hospital, one of the most
ominous findings on physical exam is the presence of
hypotension (systolic blood pressure <90 mmHg). Hypo-
tension occurred in >25% of patients and was associated
with neurologic deficits, altered mental status, myocardial
and mesenteric ischemia, limb ischemia and death in 55% of
patients. Congestive heart failure on presentation was
detected in 6.4% of IRAD patients based on the impressions
of the managing physicians but was not associated with an
increased mortality in type A or B dissection.37 HoweverFigure 6 Overall number and percentage of study patients
according to imaging study and the number and percentage
according to imaging study of first choice. TTEZ transthoracic
echocardiography. Reproduced with permission from Am J
Cardiol.38these patients were less likely to present with frank chest
or back pain and were more likely on examination to have
the murmur of aortic regurgitation.
Aortic dissection has a wide range of clinical presenta-
tions that may mimic other disorders such as stroke,
myocardial infarction, vascular embolization, and abdom-
inal pathology. Therefore, diagnosis of this disease requires
a high index of suspicion and low threshold for diagnostic
testing in patients with the appropriate risk factors.Diagnostic Strategies
Given the frequency of missed dissections, atypical
presentations, and time dependent morbidity and
mortality, effective imaging is paramount to the detection
and treatment of this disorder. The ideal imaging modality
will definitively, safely and quickly confirm the diagnosis of
AAD. It should also provide treatment specific anatomic
information such as tear location, extent of dissection,
classification, and evaluation for emergent complications
such as pericardial, mediastinal, and pleural hemorrhage.
Over the last 2 decades, there has been a shift away
from an invasive (aortography) to a noninvasive diagnostic
strategy such as computed tomography (CT), magnetic
resonance imaging (MRI), and transesophageal echocardi-
ography (TEE) for evaluating thoracic dissections. In IRAD,
almost 70% of patients had multiple imaging studies. The
1st diagnostic modality of choice was CT in 63%, then TEE in
32%, aortography in 4% and MRI in 1% (Fig. 6). The mean
number of image modalities per patient at non-U.S. sites
was significantly higher (1.94þ 0.83) than at U.S. sites
(1.71þ 0.76) (pZ 0.0005).38 With similar sensitivity, CT
and TEE have become the standard of care for the diagnosis
of AAD. CT is usually readily available and performed near
or in most emergency departments and TEE can be per-
formed at the bedside. Both are safe and usually give
complementary information for definitive treatment plans.Treatment
Ascending (type A) aortic dissection
Surgery provides definitive treatment for patients with type
A AAD. Surgical treatment aims to treat or prevent the
common and lethal complications such as aortic rupture,
stroke, visceral ischemia, cardiac tamponade and circula-
tory failure. Successful surgery and discharge from the
hospital have been associated with excellent 1- and 3-year
follow-up survival rates of greater than 90% in IRAD.
However, operative mortality for ascending aortic dissec-
tions at experienced centers varies widely between 15% and
35% and has not changed appreciably in the last two
decades.
In IRAD, 526 patients were operated on for their acute
type A dissection. Their in-hospital mortality was highly
dependent on their risk profiles prior to surgery. Patients
categorized as unstable (cardiac tamponade, shock,
congestive heart failure, CVA, coma, myocardial infarction,
acute renal failure, or mesenteric ischemia) had a much
higher in-hospital mortality of 31.4% versus 16.7% in those
Table 4 Prediction model with variables during operation
Variable Overall type
A (%)
% Among
survivors
% Among
death
Coefficient Score
assigned
p Value Death OR
(95% CI)
Age 70 years 27.3 24.1 37.4 0.58 0.6 0.04 1.79 (1.02e3.15)
History aortic valve
replacement
4.5 3.8 6.6 1.78 1.8 <0.01 5.93 (2.07e16.97)
Presenting hypotension, shock,
or tamponade
28.8 22.4 49.0 0.92 0.9 <0.01 2.52 (1.40e4.54)
Migrating chest pain 13.8 12.1 19.3 0.70 0.7 0.04 2.02 (1.02e4.02)
Any pulse deficit 28.6 25.7 37.8 0.64 0.6 0.02 1.90 (1.10e3.29)
In operation
Hypotension or shock 30.7 21.1 61.7 1.34 1.3 <0.01 3.81 (2.16e6.71)
RV dysfunction 7.0 3.6 18.2 1.59 1.6 <0.01 4.90 (2.00e12.00)
Partial arch 27.3 28.9 21.6 0.65 0.7 0.04 0.52 (0.28e0.98)
CABC 14.6 12.4 22.1 0.93 0.9 0.01 2.54 (1.23e5.24)
Reproduced with permission from J Thorac Cardiovasc Surg.39
Acute Aortic Dissection 155patient without unstable features (P< 0.001).39 Unfortu-
nately, unstable patients made up the majority of patients
operated upon in IRAD (53.5% versus46.5%). The indepen-
dent pre-operative predictors of operative mortality was
a history of aortic valve replacement (OR 3.12; CI, 1.16e
8.40, PZ 0.02), migrating chest pain (OR 2.77; CI, 1.49e
5.15, PZ 0.001), presenting hypotension (OR 1.95; CI,
1.08e3.52, PZ 0.02), presenting shock or cardiac tampo-
nade (OR 2.69; CI, 1.41e5.11, PZ 0.002), and pre-opera-
tive limb ischemia (OR 2.10; CI, 1.00e4.38, PZ 0.04). The
mean time interval from onset of symptoms to surgical
intervention for all IRAD patients showed an average of 93 h
for survivors and 37.9 h for those who died (P< 0.001). Not
surprisingly, the time period was shorter in unstable
patients than in stable patients and suggests that the major
predictors of death such as tamponade and shock also force
the hand of the surgeon to operate sooner on the most
moribund patients. Furthermore, the mortality in patients
with acute type A dissection has not changed appreciably in
the last 2 decades which might reflect both technicalFigure 7 Model 1: observed versus model probabilities of
death by score. Example: 77-year-old woman with migrating
chest pain, pre-operative cardiac tamponade, a pulse deficit,
and ST elevation. Her model score is 0.7 (age> 70)þ 0.9
(migrating chest pain)þ 1.0 (pre-operative cardiac
tamponade)þ 0.6 (pulse deficit)þ 0.6 (ST elevation). Total
scoreZ 3.8. Drawing a line straight up from her risk score, the
estimate of her surgical mortality risk is 61%. Reproduced with
permission from Ann Thorac Surg.40surgical challenges and attempted surgical intervention on
patients in extreme conditions.
In 2007, IRAD developed a bedside pre-operative and
post-operative risk prediction tool of mortality to better
educate co-providers, patients and their family regarding
the expected risk with surgical intervention. Intra-opera-
tive parameters of hypotension, right ventricular dysfunc-
tion and other parameters were added to the pre-operative
model to obtain a post-operative score (Table 4).40 Fig. 7
shows it’s application to a patient scenario. An individual’s
risk score may help the provider, patient and patient
advocates in making difficult decisions about whether to
forego surgery in critically ill patients and provide realistic
expectations of survival.
Descending (type B) aortic dissection
In the current era, surgeries for type B AAD are reserved for
complications because surgical repair has no proven supe-
riority over medical or interventional treatment in stable
patients. Patients with uncomplicated aortic dissections
confined to the descending thoracic aorta (Stanford type B
or DeBakey type III) are at present treated with medical
therapy but have recently been considered candidates for
endovascular therapy.41
In our first report on type B aortic dissection, we
included 384 patients from the IRAD registry, of which 73%
were managed medically, 15% with surgery and 12% with
endovascular interventions. In-hospital mortality was 9.6%,
32.1%, and 6.5% respectively.19 Currently, optimal thera-
peutic management of patients with complicated acute
type B dissection remains controversial. A significant one-
third of patients with acute type B dissection present with
complications such as peripheral malperfusion syndromes
and or hemodynamic instability. These patients have a high
risk of subsequent death. Endovascular treatment has
emerged over the last decade and now exceeds standard
open surgery as the dominant modality to treat most
complications of acute type B aortic dissection. In a recent
propensity analysis from IRAD, open surgical repair
was associated with an independent increased risk of in-
hospital mortality (OR: 3.41, 95% CI, 1.00e11.67,
Figure 8 Bar graph showing the incidence of mortality in type B AAD patients with different indications for surgical treatment.
Reproduced with permission from Circulation.44
156 T.T. Tsai et al.PZ 0.05).42 In-hospital complications occurred in 20% of
patients subjected to endovascular techniques, and in 40%
after open surgical repair. In-hospital mortality was signif-
icantly higher after open surgery (33.9%) than after endo-
vascular treatment (10.6%, pZ 0.002).43 However, surgical
mortality is highly dependent on the indication for surgery
(Fig. 8).44 In IRAD, endovascular treatment seems to offer
better short-term outcomes in terms of mortality and
associated complications than open repair.
Follow-up
These reports illustrate that the in-hospital mortality rate
for acute type A AAD is high but relatively stable afterFigure 9 KaplaneMeier mortality cure stratified according to the
rank test. Overall denotes comparison of all three curves. Reprodudischarge from the hospital with surgical repair whereas
hospital mortality for acute type B dissection is relatively
low but increases substantially after discharge from the
hospital. Three main management issues are predominant
in these patients during the follow-up phase and include:
medical therapy; serial imaging to detect signs of dissection
progression, redissection, or aneurysm formation; and
reoperation when indicated. Multiple factors such as
advanced age, aortic size, and false-lumen physiology may
identify a higher risk cohort for complications.
Aortic diameter has long been used as the mainstay of
prevention of aortic dissection in patients with aortic
aneurysm and for decisions to operate on remaining dis-
secting aneurysm in those recovering from acute type A or Bstatus of the false lumen. P values were calculated by the log-
ced with permission from N Engl J Med.55
Acute Aortic Dissection 157AAD. IRAD has challenged the concept that most patients
who suffer aortic dissection have enlarged aneurysms which
emphasizes the need for additional risk markers for early
surgical repair. We examined 591 patients with acute type A
dissection and found the maximum aortic diameter aver-
aged 5.3 cm and 59% had aortic diameters <5.5 cm and 40%
had aortic diameters <5.0 cm.45 Therefore, almost 60% of
patients who suffered an aortic dissection did not fall
within the current guidelines for elective aneurysm repair.
In addition to aortic diameter, a reported predictor of
poor outcomes in acute type B AAD has been the patency of
the false lumen which has been linked to false-lumen
expansion and rupture over time.46e48 Other studies have
implicated thrombus as a cause of arterial wall weakening
from local inflammation and neovascularization as a mode
of worse outcomes in abdominal aortic aneurysms (AAA).49e51Figure 10 Conceptual model of risk according to the status of
physiological consequences of false-lumen patency or thrombosis, b
with aortic dissection. Panel A shows type B aortic dissection with p
thrombus. The blood-pressure tracing shows systolic, diastolic, a
pressures in the true lumen. Panel B shows type B aortic dissection
the inner circumference of the false lumen and obstructs the reent
diastolic and mean arterial pressures in the false lumen that excee
true lumen. Panel C shows type B aortic dissection with a false lum
true lumen. The pressure within the false lumen is likely to be low
arterial pressure. Reproduced with permission from N Engl J Med.5The interplay of thrombus and flow on pressure dynamics
within the aneurysm sack has also been evaluated in
phantom models of stent graft endoleaks which suggests
increased pressure in the lumen with the presence of both
flow and thrombus.52e54 In response to clinical anecdotes of
patients with acute type B dissections in the recovery
phase, who exhibited tremendous expansion of the false
lumen in the presence of partial thrombosis, IRAD subse-
quently evaluated the impact of partial thrombosis of the
false lumen on long-term outcomes in patients with chronic
type B aortic dissection. Partial thrombosis of the false
lumen was present in 33.8% of acute type B aortic dissec-
tion on imaging and was a significant independent predictor
of death at 3 years (RR, 2.69; 95% CI, 1.45e4.98; PZ 0.002)
showing a 3-year mortality of 31.6% (Fig. 9).55 The
conceptual model explaining the increased mortality in thisthe false lumen: The figure shows a proposed model of the
ased on hemodynamic studies in ex vivo models and in patients
atent proximal and patent distal reentry tears in the absence of
nd mean arterial pressures in the false lumen similar to the
with a patent entry tear and partial thrombosis that occupies
ry tears, forming a blind sac. The blood-pressure tracing shows
d the pressures seen in Panel A, with identical pressures in the
en filled with thrombus and no longer communicating with the
and nonpulsatile. BP denotes blood pressure, and MAP mean
5
158 T.T. Tsai et al.patient subset challenges the therapeutic landscape in the
recovery phase of these patients and resurrects support for
treatments that encourage remodeling of the false channel
(Fig. 10).
IRAD: Future Directions
As IRAD has already revolutionized the contemporary
understanding of acute aortic conditions and introduced
the concept of acute aortic syndromes, the attitude in the
medical community towards dissection and its precursors
(such as intramural hematoma) has already changed.26,56,57
There is growing interest in an early and definitive
(confirmatory) diagnosis of acute aortic syndrome for
prognostic purposes. Moreover, with the new data on the
incidence and outcomes of AAD, the medical community
has understood the alarming signal sent out by IRAD which
has heightened the awareness of the disease and the
importance of pathways in the hospital environment and in
referring networks in the attempt to manage acute aortic
syndromes at a high level of excellence. This task may
require expert platforms such as regional aortic centers to
meet an increasing demand for the delivery of diagnostic
and therapeutic care. The problems have been recognized
and the efforts to improve care are currently being moni-
tored in IRAD. In addition to the mission of IRAD to both
enlighten the understanding of acute and chronic aortic
conditions and to offer appropriate expedited treatment,
IRAD will branch out to regional activities enabling the
comparison of genetic clustering and regional idiosyncrasies
and will focus on genetic sub-studies as well as regional
differences in treatment strategies.
Finally, the access to acute cases of suspected and
confirmed aortic dissection will provide the opportunity to
look at early biomarkers potentially instrumental in the
prediction of aortic catastrophes, similar to the impact of
troponins for acute coronary syndrome.
Conclusions
The IRAD activities emerged from the urgent need for
contemporary data on acute aortic dissection, as strongly
felt by its founders in 1996. Since then the textbook on
aortic dissection has been expanded and offers updated
highly valuable and realistic data on diagnostic and thera-
peutic strategies as well as outcomes of acute aortic
syndrome at the wake of the 3rd millennium.
There is no comparabledatabase available in theworld that
provides contemporary, multi-national outcomes data for
surgical, endovascular andmedical therapy in various forms of
acute aortic syndromes. Thus, with contemporary information
on acute aortic conditions, IRAD is unique and provides a valu-
able platform formodern strategic planning and teaching, and
servesat the sametime (on the scientific scope)asahypothesis
generating source of new information on an old disease.
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